We further explored the correlation between NCAPG2 and clinical characteristics of LGG and we determined that increased NCAPG2 expression was associated with poor clinical characteristics, including higher tumor grade, IDH mutation status, 1p/19q chromosome co-deletion, and primary therapy outcome, OS event, DSS event, and PFS event (Figures 2A–G). The gene discussed is NCAPG2; the disease is neoplasm.